M.Sc

Gracure Pharmaceutical Ltd. is a Delhi based pharmaceutical company, established in 1992 by Mr. A.S Bhargava with the vision of making world class affordable medicines. Gracure is a research driven forward looking pharmaceutical company with expertise in development of various finished dosage. Gracure R&D and EU-GMP approved Manufacturing Unit is located in Bhiwadi, Rajasthan.

Post : Sr. Officer/ Executive – QC

Bioclinica is utilizing data and technology to enable more efficient trial conduct. We are looking at ways to reduce the size of the trials, provide greater clarity into the effect of the drug, and to reduce the amount of complexity in the trial. We do this by improving trial design and utilizing advanced analytics to identify patients who would be high responders for a particular clinical trial.

Post : Drug Safety Associate II

The wave of globalization has propelled the expansion of Indian pharma sector. India is amongst the top 10 countries of the world, in terms of volume and value of Pharmaceutical products. Enthusiastic and entrepreneurial efforts have turned Gujarat into the hub of Pharma industry.  The innovative and translational approach of the Indian scientists resulted in paradigm shift from industrial age to knowledge enriched economy.

National Institute of Food Technology Entrepreneurship and Management (NIFTEM) was conceptualized by Government of India on persistent demand of the food industry to have an apex body as a "One Stop Solution Provider" for the various problems of the sector. Ministry of Food Processing Industries, Government of India has set up this institute with an initial investment of Rs. 500 crore (US $100 million). The institute is spread over an area of 100 acres.

The Rajiv Gandhi Centre for Biotechnology (RGCB) is an autonomous national institute of the Government of India, Ministry for Science & Technology, Department of Biotechnology. The mandate of the institute is discovery, innovation and translation in biotechnology and disease biology. At RGCB, our todays are committed to making discoveries that lead to a better tomorrow. RGCB prides itself for innovative research that integrates theory, modeling, simulation, experimental translational and clinical sciences.

The dreams of its founding fathers took shape in 1984 in the form of Shanmugha College of Engineering, which is now renamed, SHANMUGHA ARTS, SCIENCE, TECHNOLOGY & RESEARCH ACADEMY (SASTRA).  Our programmes, infrastructure, teaching-learning, etc., are among the country's finest. SASTRA has always been proactive in its academic planning and believes in gaining the first-mover advantage. As a testimony to this, the Government of India has conferred the Deemed University status to SASTRA on April 26, 2001 under section 3 of the UGC Act, 1956.

Regional Centre for Biotechnology (RCB), an Institution of national importance established by the Department of Biotechnology, Govt. of India, with regional and global partnerships synergizing with the programmes of UNESCO. The primary focus of RCB is to provide world class education, training and conduct innovative research at the interface of multiple disciplines to create high quality human resource in disciplinary and interdisciplinary areas of biotechnology in a globally competitive research milieu.

Janssen India, the pharmaceutical division of Johnson & Johnson India, is dedicated to addressing and solving some of the most important unmet medical needs of our time in India, in oncology, immunology, neuroscience and analgesia, dermatology, infectious diseases and metabolic diseases. Driven by a strong dedication to the health and well-being of patients, Janssen India brings innovative products, services and solutions to people throughout the world.

Optimus was established in the year 2004 as custom synthesis laboratory by a team of Technocrats. It is one of the fastest growing Manufacturer in Active Pharmaceutical Ingredients (APIs) and Finished dosages. Optimus Research Center for API & Formulations was set-up as a centralized Research and Development center to focus on Generic product developments suitable for regulated markets.